Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 5:27 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1369–1392 of 1,602 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Skin Patch Clear all

Conditions: Opiate Addiction, Pregnancy, Contraceptive Behavior, Sexual Behavior
Interventions: Nexplanon (etonogestrel contraceptive implant), Standard postpartum contraceptive care; Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older · Female only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Healthy
Interventions: lidocaine topical system 1.8%, lidocaine patch 5%; Drug
Lead sponsor: Scilex Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Dilworth, Minnesota

Conditions: Eczema
Interventions: hydrogel patch, Triamcinolone (TAC) 0.1% cream; Device · Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Evaluate the Use of a New Mesh Type in Open Inguinal Hernia Repair
Interventions: Open inguinal hernia repair with mesh; Procedure
Lead sponsor: Owen Drive Surgical Clinic of Fayetteville; Other
Eligibility: 18 Years to 90 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2012
U.S. locations: 1
States / cities: Fayetteville, North Carolina

Conditions: Skin Cancer
Interventions: OIR Imaging; Procedure
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Not listed
Enrollment: 490 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Rib Fractures
Interventions: Placebo Patch, 4% Lidocaine Patch; Other · Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 65 Years and older
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Sharps Injuries
Interventions: VAX-ID® 2200; Device
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: Not listed
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Healthy
Interventions: Buprenorphine transdermal patch; Drug
Lead sponsor: Purdue Pharma LP; Industry
Eligibility: 18 Years to 45 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2001
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Prostate Cancer
Interventions: Transdermal Estradiol; Drug
Lead sponsor: University of Medicine and Dentistry of New Jersey; Other
Eligibility: 18 Years and older · Male only
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 6
States / cities: Freehold, New Jersey • Hamilton, New Jersey • Morristown, New Jersey + 2 more

Conditions: Cigarette Smoking
Interventions: Nicotine replacement therapy - transdermal nicotine patch, Tailored behavioral intervention, Tobacco quit line referral, Nicotine replacement therapy - nicotine gum, Nicotine replacement therapy - nicotine lozenge, Bupropion Sustained Release, Varenicline, Combination pharmacotherapy - transdermal nicotine patch + nicotine gum, Combination pharmacotherapy - transdermal nicotine patch + nicotine lozenge, Combination pharmacotherapy - transdermal nicotine patch + bupropion, Alcohol use risk reduction, Behavioral activation for the treatment of depression, Behavioral management of post-cessation weight gain; Drug · Behavioral
Lead sponsor: Iowa City Veterans Affairs Medical Center; Federal
Eligibility: 18 Years to 99 Years
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Atopic Dermatitis
Interventions: Standard-of-care treatment for AD, Accu-patch pellet; Other · Device
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Skin Resurfacing
Interventions: Fraxel® FTX Laser System; Device
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 21 Years to 60 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 5
States / cities: La Jolla, California • Miami, Florida • Naperville, Illinois + 2 more

Conditions: Pregnant, Labor
Interventions: 5% lidocaine patch, placebo patch; Drug
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 45 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Cigarette Smoking, Addiction, E Cig Use
Interventions: E cigarettes, Nicotine Replacement Therapy; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Cigarette Smoking, Nicotine Dependence
Interventions: varenicline (Chantix), bupropion (Zyban), nicotine patches; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 2
States / cities: Durham, North Carolina • Raleigh, North Carolina

Conditions: Smoking, Pregnancy
Interventions: Motivational interviewing for smoking cessation, Cognitive behaviors therapy, CBT + NRT; Behavioral · Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 181 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2003
U.S. locations: 2
States / cities: Durham, North Carolina • Fayetteville, North Carolina

Conditions: Orthostatic Intolerance
Interventions: Ganirelix acetate, 17β-Oestradiol, Progesterone; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 34 Years · Female only
Enrollment: 109 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Dermatitis, Photoallergic
Interventions: Butenafine HCl 1% (BAY1896425) - Induction Phase, Butenafine HCl 1% (BAY1896425) - Challenge Phase; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 137 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Fairfield, New Jersey

Conditions: Cardiac Arrhythmia
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Vitiligo
Interventions: Needling, Triamcinolone; Procedure · Drug
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 89 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Somerset, New Jersey

Conditions: Smoking Cessation, Biofeedback
Interventions: personalized cessation care, bio feedback, standard care; Behavioral · Other
Lead sponsor: Yale University; Other
Eligibility: 50 Years and older
Enrollment: 276 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 2
States / cities: New Haven, Connecticut • Charleston, South Carolina

Conditions: Pain
Interventions: Topical gel vehicle, Sodium lauryl sulfate 0.1%, Sodium chloride solution 0.9% (saline); Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 234 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Carlstadt, New Jersey

Conditions: Cardiac Surgery
Interventions: Pulse Oximeter; Device
Lead sponsor: Taiwan Aulisa Medical Devices Technologies, Inc.; Industry
Eligibility: 0 Days to 1 Year
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: E-cigarette Use, Withdrawal
Interventions: Transdermal Nicotine Patch, Placebo Nicotine Patch; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years to 55 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Search by objective public record fields.

Immediate Postpartum Nexplanon Placement in Opioid Dependent Women

Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy, Adult, Human Subjects

Hydrogel Patch for the Treatment of Eczema

Use of Parietex Plug and Patch Hernia System in Open Inguinal Hernia Repair

Melanoma Detection by Oblique-Incidence Optical Spectroscopy

Lidocaine Patches in Elderly Patients With Traumatic Rib Fractures

A Study of VAX-ID® 2200, a New Device for Intradermal Injections

Examine Plasma Concentrations of Buprenorphine Following Reapplication of Buprenorphine Transdermal System (BTDS) After Variable Application Site Rest Periods

Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer

Tailored Tobacco Quitline for Rural Veterans

Acupressure in Pruritus for Atopic Dermatitis

A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing

Lidocaine Patch for Relief of Pain During Epidural Placement in Laboring Patients

Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder

Tailored Smoking Cessation Treatment for LIVE FOR LIFE® Participants

Testing Pharmacological Therapies for Pregnant Smokers

Sex Hormones and Orthostatic Tolerance

Study to Find Out if Cream V61-044 Used to Treat Fungal Infections Causes an Allergic Skin Reaction to Sunlight in Healthy Participants

Patient Status Engine (PSE): EARLY FEASIBILITY AND USABILITY STUDY

Assessing the Efficacy of Needling With or Without Corticosteroids in the Repigmentation of Vitiligo

Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP)

RIPT of Ibuprofen Topical Gel

Performance of Pulse Oximeter Sensors in Neonates

Evaluation of the Electronic Cigarette Withdrawal Syndrome